1. Home
  2. ICUI vs SEZL Comparison

ICUI vs SEZL Comparison

Compare ICUI & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • SEZL
  • Stock Information
  • Founded
  • ICUI 1984
  • SEZL 2016
  • Country
  • ICUI United States
  • SEZL United States
  • Employees
  • ICUI N/A
  • SEZL N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • SEZL Diversified Financial Services
  • Sector
  • ICUI Health Care
  • SEZL Finance
  • Exchange
  • ICUI Nasdaq
  • SEZL Nasdaq
  • Market Cap
  • ICUI 3.3B
  • SEZL 3.0B
  • IPO Year
  • ICUI 1992
  • SEZL N/A
  • Fundamental
  • Price
  • ICUI $119.25
  • SEZL $83.50
  • Analyst Decision
  • ICUI Buy
  • SEZL Buy
  • Analyst Count
  • ICUI 6
  • SEZL 4
  • Target Price
  • ICUI $186.60
  • SEZL $113.75
  • AVG Volume (30 Days)
  • ICUI 285.2K
  • SEZL 849.8K
  • Earning Date
  • ICUI 11-11-2025
  • SEZL 11-06-2025
  • Dividend Yield
  • ICUI N/A
  • SEZL N/A
  • EPS Growth
  • ICUI N/A
  • SEZL 146.46
  • EPS
  • ICUI N/A
  • SEZL 2.93
  • Revenue
  • ICUI $2,372,504,000.00
  • SEZL $371,794,890.00
  • Revenue This Year
  • ICUI N/A
  • SEZL $65.77
  • Revenue Next Year
  • ICUI N/A
  • SEZL $27.29
  • P/E Ratio
  • ICUI N/A
  • SEZL $28.18
  • Revenue Growth
  • ICUI 2.96
  • SEZL 92.95
  • 52 Week Low
  • ICUI $107.00
  • SEZL $24.86
  • 52 Week High
  • ICUI $196.26
  • SEZL $186.74
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 42.14
  • SEZL 40.75
  • Support Level
  • ICUI $117.69
  • SEZL $81.84
  • Resistance Level
  • ICUI $125.00
  • SEZL $87.63
  • Average True Range (ATR)
  • ICUI 4.04
  • SEZL 4.60
  • MACD
  • ICUI -0.69
  • SEZL 1.16
  • Stochastic Oscillator
  • ICUI 23.20
  • SEZL 40.49

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

Share on Social Networks: